ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +1.4% | 51,849 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $70 | -41.7% | 50,849 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $120 | +3.4% | 50,849 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $116 | -99.9% | 50,849 | -0.6% | 0.01% | -25.0% |
| Q3 2022 | $141,000 | +12.8% | 51,149 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $125,000 | -38.1% | 51,149 | 0.0% | 0.01% | -22.2% |
| Q1 2022 | $202,000 | -10.6% | 51,149 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $226,000 | -28.5% | 51,149 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $316,000 | -22.0% | 51,149 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $405,000 | -26.0% | 51,149 | 0.0% | 0.02% | -30.8% |
| Q1 2021 | $547,000 | – | 51,149 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 245,000 | $676,000 | 0.76% |
| BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
| Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
| Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
| JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
| Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
| Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
| INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |